Health Care & Life Sciences » Biotechnology | Biotec Pharmacon ASA

Biotec Pharmacon ASA

Biotec Pharmacon ASA
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
48.33 M
Public Float
-
Biotec Pharmacon ASA
Stock Exchange Oslo Stock Exchange
EPS
NOK0.26
Market Cap
NOK200.59 M
Shares Outstanding
48.33 M
Public Float
47.88 M

Profile

Address
Siva Innovasjonssenter
Tromsø TR 9019
Norway
Employees -
Website http://www.biotec.no
Updated 07/08/2019
Biotec Pharmacon ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Beta-Glucans segments. The Enzymes segment consists of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing.

Financials

View All

Marie Roskrow
Chairman
Arne Reinemo
Director